Transversal Therapeutics is a pioneering diagnostics startup committed to transforming healthcare through the development of rapid, cost-effective, and minimally invasive electrochemical sensors for a wide range of medical applications. Our goal is to address the pressing gaps in modern diagnostics, which are often slow, costly, and lack the responsiveness and sensitivity essential for critical decision-making in healthcare. In areas where quick, accurate information is paramount, current diagnostic technologies frequently fall short, leaving patients and providers underserved.
Our mission is to expand the reach of electrochemical diagnostics beyond the traditional laboratory settings and into broader healthcare contexts. By developing sensors that are affordable, portable, and easily integrated into point-of-care and even at-home diagnostics, we aim to empower both healthcare professionals and patients with real-time data. This approach can transform patient outcomes across multiple domains, from routine screenings to the monitoring of chronic conditions and the management of acute illnesses.
With a focus on versatility and accessibility, we are committed to setting a new standard for diagnostics, ensuring that more individuals can benefit from timely, accurate, and actionable health information.
Our team brings decades of collective experience in developing electrochemical (EC) sensors, a technology known for its precision, adaptability, and ease of use. Electrochemical sensors offer significant advantages—they are highly sensitive, capable of rapid quantitative measurements, and can be designed to detect a diverse array of biomarkers. At Transversal Therapeutics, we are harnessing these attributes to bring a new level of simplicity, speed, and sensitivity to the diagnostics field.